Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Otonomy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Otonomy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Otonomy Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Otonomy Acquires Assets and Patent Rights From NeuroSystec 11
Venture Financing 12
Otonomy Raises US$49 Million In Series D Venture Financing 12
Otonomy Raises US$46 Million In Series C Venture Financing 14
Partnerships 16
Otonomy Enters into Co-Promotion Agreement with Mission Pharmacal 16
Licensing Agreements 17
Otonomy Enters into Licensing Agreement with Ipsen 17
Otonomy Enters into Licensing Agreement with Durect 18
Equity Offering 19
Otonomy Raises USD115 Million in Public Offering of Shares 19
Otonomy Raises USD86 Million in Public Offering of Shares 21
Otonomy Completes Underwriters Exercise of Over-Allotment Option of IPO for USD115 Million 23
Otonomy Inc – Key Competitors 25
Otonomy Inc – Key Employees 26
Otonomy Inc – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Strategy And Business Planning 28
Nov 27, 2017: Otonomy Announces Plan to Focus Resources on Development Programs 28
Financial Announcements 29
Nov 05, 2018: Otonomy reports third quarter 2018 financial results and provides corporate update 29
Aug 08, 2018: Otonomy reports second quarter 2018 financial results and provides corporate update 31
May 09, 2018: Otonomy Reports First Quarter 2018 Financial Results and Provides Corporate Update 33
Mar 08, 2018: Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 34
Nov 08, 2017: Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update 36
Aug 03, 2017: Otonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update 37
May 04, 2017: Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update 39
Mar 02, 2017: Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 41
Product News 43
07/18/2017: Otonomy Announces FDA Acceptance of OTIPRIO Supplemental New Drug Application Filing for Acute Otitis Externa 43
Clinical Trials 44
Nov 08, 2017: Otonomy Reports Positive Results from AVERTS-2 Phase 3 Trial of OTIVIDEX in Patients with Ménière’s Disease 44
Aug 30, 2017: Otonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX in Patients with Menieres Disease 45
Jun 22, 2017: Otonomy Announces Successful End-of-Phase 2 Review by FDA for OTIPRIO in Acute Otitis Media with Tympanostomy Tubes 46
Jun 20, 2017: Otonomy to Host Key Opinion Leader Meeting for Investors on Meniere’s Disease 47
May 12, 2017: Otonomy Announces OTIPRIO Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting 48
Jan 19, 2017: Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss 49
Jan 05, 2017: Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO in Patients with Acute Otitis Externa 50
Other Significant Developments 51
Jan 09, 2018: Otonomy Provides Corporate and Product Pipeline Update 51
Sep 13, 2017: Otonomy Provides Business and Financial Update 53
Jan 09, 2017: Otonomy Provides Corporate and Product Pipeline Update 54
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
Otonomy Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Otonomy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Otonomy Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Otonomy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Otonomy Acquires Assets and Patent Rights From NeuroSystec 11
Otonomy Raises US$49 Million In Series D Venture Financing 12
Otonomy Raises US$46 Million In Series C Venture Financing 14
Otonomy Enters into Co-Promotion Agreement with Mission Pharmacal 16
Otonomy Enters into Licensing Agreement with Ipsen 17
Otonomy Enters into Licensing Agreement with Durect 18
Otonomy Raises USD115 Million in Public Offering of Shares 19
Otonomy Raises USD86 Million in Public Offering of Shares 21
Otonomy Completes Underwriters Exercise of Over-Allotment Option of IPO for USD115 Million 23
Otonomy Inc, Key Competitors 25
Otonomy Inc, Key Employees 26
List of Figures
Otonomy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Otonomy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Otonomy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9